Remedium Bio company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

remedium-bio.com

Founded Year

2020

Stage

Convertible Note | Alive

Total Raised

$1.37M

Last Raised

$1.37M | 8 mos ago

About Remedium Bio

Remedium Bio is a Needham, Massachusetts-based gene therapy company focused on the development of treatments for a broad range of diseases.

Remedium Bio Headquarter Location

1116 Great Plain Avenue

Needham, Massachusetts, 02492,

United States

978-467-5217

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Remedium Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Remedium Bio is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Latest Remedium Bio News

08:30 ET Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Mass...

Jan 10, 2022

News provided by Share this article Share this article BOSTON, Jan. 10, 2022 /PRNewswire/ -- Remedium Bio, Inc., a biotechnology company developing novel gene therapies, is pleased to announce it has entered into a Sponsored Research Agreement with the University of Massachusetts Boston to complete pre-clinical efficacy studies on Type 1 and Type 2 Diabetes pipeline candidates. The collaboration will evaluate platform technology for the treatment of Diabetes, with translational potential to the broader Remedium pipeline of single-injection potentially disease-modifying gene therapies. We believe that any disease can be cured. - Remedium Bio. The initiation of this research program is a transformational milestone for Remedium. The research is being led by Dr. Kai Zou, PhD, Assistant Professor at the Department of Exercise and Health Sciences under the Robert and Donna Manning College of Nursing and Health Sciences at the University of Massachusetts Boston. Dr. Zou's laboratory has expertise in characterizing metabolic dysfunction associated with Diabetes and has extensive know-how in the fields of endocrine dysregulation, insulin resistance, impaired glucose metabolism, and associated molecular pathophysiological mechanisms. Dr. Zou has extensive expertise in endocrinology having generated high-impact publications in journals including the Journal of Physiology, Surgery, Physiological Genomics, and International Journal of Obesity. "The initiation of this research program is a transformational milestone for Remedium" said Frank Luppino, CEO of Remedium Bio. "Through this partnership, Remedium will expand its development portfolio and validate our gene-therapy dose-adjustment platform, which has broad therapeutic applicability beyond the currently targeted indications". About Remedium Remedium Bio, Inc. is a preclinical-stage biotechnology company developing novel gene therapies for a broad range of highly debilitating diseases. The company's R&D approach focuses on modularly combining proven technologies to treat well-characterized disease pathology streamlining and de-risking elements of the product development process. Remedium's pipeline includes a lead candidate first-in-class, single-injection, potentially disease-modifying gene therapy treatment for Osteoarthritis and gene therapy treatments for the management of Type 1 and Type 2 Diabetes. To learn more, visit www.remedium-bio.com . About UMass Boston The University of Massachusetts Boston is deeply rooted in the city's history, yet poised to address the challenges of the future. Recognized for innovative research, metropolitan Boston's public university offers its diverse student population both an intimate learning environment and the rich experience of a great American city. UMass Boston's colleges and graduate schools serve 16,000 students while engaging local and global constituents through academic programs, research centers, and public service. To learn more, visit  www.umb.edu .

  • When was Remedium Bio founded?

    Remedium Bio was founded in 2020.

  • Where is Remedium Bio's headquarters?

    Remedium Bio's headquarters is located at 1116 Great Plain Avenue, Needham.

  • What is Remedium Bio's latest funding round?

    Remedium Bio's latest funding round is Convertible Note.

  • How much did Remedium Bio raise?

    Remedium Bio raised a total of $1.37M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.